Nektar PEG-Irinotecan Moves Into Phase II For Colorectal Cancer

By applying Nektar’s PEGylation technology to Camptosar, the drug may demonstrate more powerful and tolerable anti-tumor activity.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet